In a GDM rat model, inhibition of miR-873, which targeted IGFBP2, was shown to regulate insulin resistance and alleviate myocardial injury by activating the PI3K/AKT/mTOR signaling pathway, thereby mitigating the progression of GDM (206). Here, AKT1 is linked to gestational diabetes.